Global Perspectives and Future Directions in Women’s Cancer · Charité Mayo Conference in Berlin: “Global Perspectives and Future Directions in Women’s Cancer”. This special

April 3–6, 2019

Berlin, Germany

th InternationalCharité MayoConference

10Global Perspectives andFuture Directions inWomen’s Cancer

www.charite-mayo.de

CO

NFE

REN

CE

PR

OG

RA

M

Ch

arité M

ayo C

on

feren

ce

3

Greeting Words

Wednesday, April 3, 2019 Breast Cancer

Thursday, April 4, 2019 Cervical and Endometrial Cancer, Rare Tumors

Friday, April 5, 2019 Ovarian Cancer

Saturday, April 6, 2019 Symposia

Registration

Poster Session

General Information

Travel and Hotel

Speakers, Surgeons, Chairs

Sponsors, Exhibitors

Social Program

Table of Contents

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 – 5

. . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 – 9

. . . . . . . . . . . . . . . . . . . . . . . . . . . 10 – 11

. . . . . . . . . . . . . . . . . . . . . . . . . 12 – 13

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 – 15

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 – 20

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

. . . . . . . . . . . . . . . . . . . . . . . . 22 – 23

. . . . . . . . . . . . . . . . . . . . . . . . . . . 24 – 25

. . . . . . . . . . . . . . . . . . . 26 – 29

. . . . . . . . . . . . . . . . . . . . . . . . 31 – 33

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

IMPRINT

Layout, SettingJörg Eickeler, Beratung Organisation Veranstaltung, Düssseldorf/Germany

Printdm druckmedien gmbh, München/Germany

Imagescover page: Charité + Wiebke Peitz/Charité · page 4: Charité ·page 5: Senatskanzlei Berlin · page 24: Charité · page 34: Charité +Clärchens Ballhaus, Berlin

Ch

arit

é M

ayo

Co

nfe

ren

ce

Greeting Words

4

Dear Colleagues,

It is our pleasure to invite you to this year’s 10th InternationalCharité Mayo Conference in Berlin: “Global Perspectives andFuture Directions in Women’s Cancer”.

This special anniversary meeting will feature the hottesttopics in gynecological oncology including 12 hours oflive surgeries, debates, intensive workshops and the latestbreakthroughs with more than 700 participants from allover the world.

This year we are particularly proud to host two specialsymposia: the IGCS-PARSGO Joint Symposium to discusspractical issues of clinical trials, and the TOC-ENGOT-EUTROC-INTEGRATE Alliance Symposium focusing ontranslational research.

We are convinced that this extraordinary dialogue betweeninternational experts and the participants will significantlyimpact clinical routine and the future of women’s cancermanagement.

We would be very pleased to welcome you personally inthe German capital.

Sincerely yours,

Prof. Dr. Jalid Sehouli Prof. Dr. Jens-Uwe Blohmer

Conference Chairs and Scientific Committee10th International Charité Mayo Conference

Prof. Dr. J.-U. BlohmerProf. Dr. J. Sehouli

Ch

arité M

ayo C

on

feren

ce

5

Berlin would like to extend a warm welcome to theparticipants in the international Charité-Mayo Conferencebeing held here in Germany’s capital city.

Now being held for the tenth time, this conference hasestablished itself as a prestigious meeting of renownedexperts from around the world who deal withgynecological tumors. It serves as a platform for exchangeon the latest diagnostic, treatment, and aftercareprocedures, thereby promoting the medical advances onwhich many tumor patients pin their hopes.

As a center for cutting-edge science, research, andmedicine, our city offers outstanding conditions for aninspiring gathering. Germany’s capital is well on the wayto becoming Europe’s leading health care location by2030. And with the Charité hosting the conference, therewill be abundant opportunities for exchange with Berlinphysicians and scientists whose research, practice, andteaching are world-class. With all this in mind, I would liketo wish all of the participants a productive Charité-MayoConference, thought-provoking discussions with yourcolleagues, and an enjoyable stay in Berlin that you willlong remember.

Michael MüllerGoverning Mayor of Berlin

Michael Müller

Ch

arit

é M

ayo

Co

nfe

ren

ce

Scientific Program

8

WEDNESDAY, APRIL 3, 2019BREAST CANCER

8.20 am Welcome Address of the HostsJ.-U. Blohmer, W. A. Cliby, J. Sehouli

8.30 am LIVE SURGERY

Moderation: J. Heil, S. Paepke

Reduction Techniques, Lipofilling Techniques, Surgery of Lymphedema, Microanastomoses, Implant Based Reconstruction

Surgeons: J.-U. Blohmer, O. Camara, S. Kümmel, R. Maatouk, C. Kolberg-Liedtke

12.30 pm Lunch Break

1.30 pm Welcome AddressProf. Dr. med. Axel Radlach Pries, MD

Dean, Charité – Universitätsmedizin Berlin

LECTURES AND PRO/CON SESSIONS

Chair: U. Keilholz

1.35 pm Keynote Lecture: Outlook in the Therapy of Breast Cancer from a Translational Scientist’s Point of View

A. Lee

Chair: O. Camara, S. Paepke

2.05 pm Locoregional Management of the Breast After Neoadjuvant Chemotherapy

J. Heil

2.25 pm How to Avoid the Jumping Breast Phenomenon After Implant Reconstruction

S. Kümmel

2.45 pm Reduction of Capsular Fibrosis Rate Using Meshes and Acellular Dermal Matrices?

J.-U. Blohmer

3.05 pm Conservative Techniques for Treatment of Postoperative Lymphedema

A. Reißhauer

3.25 pm Surgical Techniques for Treatment of Postoperative Lymphedema

O. Camara

3.45 pm Coffee Break

Ch

arité M

ayo C

on

feren

ce

9

Chair: J.-U. Blohmer, C. Kolberg-Liedtke

4.15 pm Neoadjuvant Chemotherapy – Why, When and How?

L. Pusztai

4.45 pm Therapy of Triple Negative Breast CancerC. Kolberg-Liedtke

5.00 pm Updates on Mechanisms of Endocrine Resistance S. Oesterreich

5.30 pm How to Avoid Adjuvant Over- or Undertherapy Using Molecular Tests

O. Gluz

5.45 pm Overcoming Endocrine Resistance in Hormone Receptor Positive Breast Cancer

M. Liu

6.05 pm Breast Cancer and Diabetes MellitusN. V. Ivanov

6.25 pm Case Discussions i.a. on Biosimilars, Therapy Resistance, Immunology V. Kiver, M. Schubert, G. von Waldenfels

6.40 pm End of Program

4.00 pm to 6.00 pm · parallel to main program

INTENSIVE WORKSHOP OVARIAN CANCERPreoperative Management, Surgical,Anesthesiological and PerioperativeManagement, Surgical Techniques,ERAS and more

ERAS, PrehabilitationM. Körber, R. Armbrust

Opiate Reduction Perioperative / Opiate CrisesS. C. Dowdy

Indication, Contraindication, TechniquesJ. Sehouli

Cytoreductive Surgery, Middle and Lower AbdomenW. A. Cliby

Cytoreductive Surgery, Upper AbdomenC. Fotopoulou

limited number of participants · extra charge · only in combination with aconference ticket

Ch

arit

é M

ayo

Co

nfe

ren

ce

Scientific Program

10

THURSDAY, APRIL 4, 2019CERVICAL AND ENDOMETRIAL CANCER,RARE TUMORS


Moderation: W. A. Cliby, C. Marth, K. Pietzner

Cervical, Endometrial and Vulvar Cancer, Exenteration, Complex Endometriosis Surgery

Surgeons: V. Chiantera, S. Mahner, M. Z. Muallem, J. Neymeyer, J. Sehouli

during Live Surgery:

The Most Challenging Case of the Year R. Chekerov



Cervical Cancer

Chair: S. C. Dowdy, W. Lichtenegger

1.30 pm Pro/Con: Early Stage Cervical Cancer – Is Minimal Invasive Surgery Harming?

} Harming: D. Cibula} Not Harming: G. Scambia

2.10 pm Early Stage Cervical Cancer} Trachelectomy or Cone Biopsy?

N. R. Abu-Rustum} Current Aspects of Uterus Transplantation

S. G. Tullius, G. Inci

2.50 pm Pro/Con: Locally Advanced Cervical Cancer} Primary Radio-Chemotherapy

S. Marnitz-Schulzevs.} Primary Surgery

M. Z. Muallem


Ch

arité M

ayo C

on

feren

ce

11

Endometrial Cancer, Rare Tumors

Chair: A. Poveda, P. Wimberger

4.00 pm Conservative Treatment of Early Stage Endometrial Cancer

S. C. Dowdy

4.20 pm New Medical Therapies in Endometrial CancerM. R. Mirza

4.40 pm Immunotherapy in Uterus and Cervical Cancer – Where are we?

J. S. Berek

5.00 pm Pro/Con: Molecular Profiling in Endometrial Cancer

} Classical HistologyN. Colombovs.} Molecular Based Histology

K. C. Podratz

5.40 pm Current Aspects of Surgical and Medical Therapies of Gynecological Sarcomas J. Sehouli

5.55 pm Endometriosis and Gynecological Cancers: Etiology and Treatments S. Mechsner


4.00 pm to 6.00 pm · parallel to main program

INTENSIVE WORKSHOP BREAST SURGERYOncoplastic and Reconstructive Surgery

Mesh, ADM, Lipofilling,Tumor Position Adapted Reductionand othersJ.-U. Blohmer, O. Camara, J. Heil, S. Kümmel, S. Paepke


Ch

arit

é M

ayo

Co

nfe

ren

ce

Scientific Program

12

FRIDAY, APRIL 5, 2019OVARIAN CANCER


Moderation: A. du Bois, L. Chiva, B. Monk

Ovarian Cancer and Sarcomas Surgeons: R. Chekerov, C. Fotopoulou, M. Z. Muallem, G. Scambia, J. Sehouli

during Live Surgery:

The Most Challenging Case of the Year G. Inci



Chair: L. Chiva, W. A. Cliby

1.30 pm HIPEC: Hype or Hope? C. Fotopoulou

1.50 pm Pro/Con: Surgery in Relapsed Ovarian Cancer} Pro: A. du Bois} Con: T. Herzog

2.30 pm Role of Lymph Node Dissection in Early, Low and High Grade Ovarian Cancer W. A. Cliby

2.50 pm Role of Lymph Node Dissection in Advanced Ovarian Cancer J. Sehouli

3.10 pm Prediction of Surgical Outcome: Tumor Biology vs. Surgical Skills E. I. Braicu


Ch

arité M

ayo C

on

feren

ce

13

Chair: A. González Martín, J. Sehouli

4.00 pm PARP Therapies: Who are the Best Candidates and who Not? J. Ledermann

4.20 pm Role of Antiangiogenesis in Gynecological Malignancies: Who are the Best Candidates and who Not? S. Pignata

4.40 pm Low Grade Ovarian Cancer: Best Medical Treatment B. Monk

5.00 pm Immunotherapy in Ovarian Cancer: How to Optimize the Benefits O. Dorigo

5.20 pm New Targeted Therapies in Breast Cancer and Gynecological Cancers: Prevention and Management of Complication K. Pietzner

5.40 pm Similarities and Differences of Asian and Non-Asian Gynecological Cancer Patients K. Fujiwara


Ch

arit

é M

ayo

Co

nfe

ren

ce

Scientific Program

14

SATURDAY, APRIL 6, 2019SYMPOSIA

IGCS PARSGO JOINT SYMPOSIUM

Chair: T. Herzog, A. Poveda, J. Sehouli

9.00 am How to Motivate Patients for Clinical Trials J. Sehouli

9.30 am What are the Best Designs for Clinical Trials with Targeted Therapies? M. Bookman

10.00 am How to Interpret Data Trials in Rare Tumors M. Seckl

10.30 am Current and Future Aspects in Cervical Screening

} The Turkish Experience: M. Gultekin} Global Perspectives: A. Kaufmann

11.00 am Coffee Break

JOINT SYMPOSIUM:TOC, ENGOT, EUTROC, INTEGRATE

Block I: Tailored Treatment of Ovarian Cancer

Chair: E. I. Braicu, N. Concin

11.30 am Early Stages: Is there a Signature that can Predict Relapse? M. Birrer, H. Kulbe

12.00 pm Can we Predict Response to Anti-Angiogenetic Drugs? C. Gourley

12.20 pm Understanding PARPi Sensitivity or Addressing Platinum Sensitivity A. E. Wahner-Hendrickson

12.40 pm Is there a Signature for Long-Term Survival with Ovarian Cancer? H. Woopen

1.00 pm Lunch Break + POSTER SESSION Poster Committee: P. Achimas-Cadariu,

R. Armbrust, E. I. Braicu, N. Concin, H. Kulbe

Ch

arité M

ayo C

on

feren

ce

15

Block II: Evidence Based and Personalized Medicine – Complementary Approaches?

Chair: C. Kolberg-Liedtke, C. Gourley

2.00 pm Chances and Limits of Next Generation Sequencing for Treatment Decision M. Hummel

2.20 pm What are the Clinical Consequences of Tumor Profiling in Gynecological Oncology? R. Chekerov

2.40 pm Early Recognition of Therapy Resistance by Patient Reported Outcome M. Karsten

3.00 pm Role of PARP Therapies in Breast Cancer D. Speiser

3.20 pm Modifiers of Endocrine Resistance like CDK4/6 and PiK3CA Inhibitors: Who benefits? J.-U. Blohmer

3.40 pm The Microbiome in Prediction of Cancer Therapy Response J. Grabowski

4.00 pm Closing Session Presentation of the three Best Posters Closing Words and Farewell J.-U. Blohmer, W. A. Cliby, J. Sehouli

9.00 am to 11.00 am · parallel to main program

INTENSIVE WORKSHOP CERVICAL CANCERThe Current Aspects of Cervical Cancer Therapy

Early Cervical Cancer: How to Modify the Radicality?R. Querleu

A Sentinel Lymph Node Mapping AlgorithmN. R. Abu Rustum

Nerve Sparing Radical Hysterectomy: Why? And Whoare the Candidates?M. Z. Muallem


FAX

: +49 (0)211/3033554

Jörg EickelerBeratung

Organisation

VeranstaltungN

eanderstraße 20

40233 Düsseldorf

GERM

AN

Y

10th In

ternatio

nal C

harité M

ayo C

on

ference

Ap

ril 3–6, 2019· Berlin

hospital, institute, p

ractice etc.

o chief p

hysiciano

senior physician

o p

hysiciano

assistant physician

o p

hysician in private p

racticeo

other (e.g. scientist)

The following address is

o hom

e addresso

office address

email

street, no

countryp

ost codetow

n

area coe, phone num

berfax

academic title

last name

first nameo

female

o m

ale

Online Registration at: www.charite-mayo.dei


BOOKING

TOTAL CONFERENCE FEEo EUR 350 o EUR 250 for members of AGO, ESGO, NOGGO or PARSGO

as well as assistant physicians

DAY TICKETo EUR 130 o EUR 100 for members of AGO, ESGO, NOGGO or PARSGO

as well as assistant physicians

o WED April 3 o THU April 4 o FRI April 5 o SAT April 6

INTENSIVE WORKSHOP OVARIAN CANCERWednesday, April 3, 2019

o EUR 50 extra charge (only in combination with a conference ticket)

INTENSIVE WORKSHOP BREAST SURGERYThursday, April 4, 2019


INTENSIVE WORKSHOP CERVICAL CANCERSaturday, April 6, 2019


WELCOME EVENINGThursday, April 4, 2019

o ______ person(s) at EUR 20 per person

FESTIVE EVENINGFriday, April 5, 2019

o ______ person(s) at EUR 50 per person

TOTAL AMOUNT: ____________________


PAYMENT BY DEBIT ADVICE PROCEDURE*

*) SEPA DEBIT ADVICE PROCEDURE only within the European Union

Worldwide Registration by credit card: next page

BIC (Business Identifier Code of the bank)

account holder

IBAN (International Bank Account Number)

bank, town

I hereby give Jörg Eickeler, Beratung Organisation Veranstaltung a revocable title to collect thefees for the Charite Mayo Conference when due from my account by SEPA debit advice procedure.If there should not be enough funds on my account, the account-holding bank does not have theobligation to honour the payment. In the case of non-payment or incorrect details on the bankaccount, I untertake to pay Jörg Eickeler, Beratung Organisation Veranstaltung for the coststhereby incurred. Portioned encashments in debit advice procedures shall not be made.

TERMS AND CONDITIONS OF REGISTRATIONThe closing date for pre-registration is March 29, 2019. Following receipt of your fully completedregistration form, we will confirm your registration by email or fax. In case of cancellation (inwriting only) up to four weeks prior to the start of the event, an administration fee of EUR 50 perperson will be charged. In case of cancellation up to two weeks prior to the event, half of theparticipation fee shall be payable. Payment of the full participation fee shall be due in the eventof cancellation at a later date or failure to appear at the event. Naturally, you have the right tonominate a replacement participant. The event organizer reserves the right to make alterationsto the program without prior notification.I hereby confirm my booking and accept the terms and conditions of registration.

town, date, signature, stamp

21

Poster Session

during the

JOINT SYMPOSIUMTOC, ENGOT, EUTROC, INTEGRATE

Saturday, April 6, 2019, 1.00 pm – 2.00 pm

Topicsbasic/translational science; predictive and prognosticbiomarkers; gynecologic pathology and disease pathogenesis;breast cancer; cervical cancer; rare tumors and gestationaltrophoblastic neoplasia; ovarian cancer; uterine cancerincluding sarcoma; vulvar and vaginal cancer; surgicaltechniques and preoperative management; symptommanagement; palliation

Publication of abstractsAll papers accepted by the Selection Committee will bepublished as supplement of the Anticancer Research Journalwith the friendly assistance of Anticancer Research.

Poster awardsThe independent Poster Award Committee (P. Achimas-Cadariu, R. Armbrust, E. I. Braicu, N. Concin, H. Kulbe) willchoose three posters from all the posters presented at theconference, which will be awarded a prize of EUR 500 each.The prize winners will be announced at the final conferencesession on Saturday, April 6, 2019.

Ch

arité M

ayo C

on

feren

ce

Poster SessionOnline Registration at: www.charite-mayo.dei

PAYMENT BY CREDIT CARD

card verification number

credit card owner

credit card number

valid until: month / year

I hereby give Jörg Eickeler, Beratung Organisation Veranstaltung a revocable title to collect thefees for the Charite Mayo Conference when due from my credit card. In the case of non-paymentor incorrect details on the credit card. I untertake to pay Jörg Eickeler, Beratung Organisation Veranstaltung for the costs thereby incurred.

TERMS AND CONDITIONS OF REGISTRATIONThe closing date for pre-registration is March 29, 2019. Following receipt of your fully completedregistration form, we will confirm your registration by email or fax. In case of cancellation (inwriting only) up to four weeks prior to the start of the event, an administration fee of EUR 50 perperson will be charged. In case of cancellation up to two weeks prior to the event, half of theparticipation fee shall be payable. Payment of the full participation fee shall be due in the eventof cancellation at a later date or failure to appear at the event. Naturally, you have the right tonominate a replacement participant. The event organizer reserves the right to make alterationsto the program without prior notification.I hereby confirm my booking and accept the terms and conditions of registration.

town, date, signature, stamp

oMASTERCARD

o VISA CARD

/

The card verification number is printed onthe back side and has three digits.

Ch

arit

é M

ayo

Co

nfe

ren

ce

General Information

22

VENUELangenbeck-Virchow-HausLuisenstraße 58/5910117 Berlin / Germany

DATEApril 3–6, 2019

SCIENTIFIC COMMITTEEProf. Dr. med. Jalid SehouliDepartment of Gynecologywith Center for Oncological SurgeryEuropean Competence Center for Ovarian CancerCharité – Universitätsmedizin BerlinCampus Virchow-KlinikumAugustenburger Platz 1, 13353 Berlin / GermanyProf. Dr. med. Jens-Uwe BlohmerDepartment of Gynecology and Breast CenterCharité – Universitätsmedizin BerlinCampus Charité MitteCharitéplatz 1, 10117 Berlin / Germany

ORGANIZING COMMITTEEProf. Dr. med. Jalid SehouliProf. Dr. med. Jens-Uwe BlohmerProf. Dr. med. Elena Ioana BraicuPriv.-Doz. Dr. med. Dr. med. (syr) Mustafa Zelal MuallemCharité – Universitätsmedizin Berlin, Berlin / GermanyProf. Dr. William A. ClibyProf. Dr. Sean C. DowdyMayo Clinic, Rochester, MN / USA

INFORMATION, ORGANIZERJörg EickelerBeratung Organisation VeranstaltungNeanderstraße 20, 40233 Düsseldorf / GermanyTel. +49 (0)211/3033224, Fax +49(0)211/[email protected], www.eickeler.org

HOMEPAGEwww.charite-mayo.de

REGISTRATIONOnline registration at: www.charite-mayo.dePreregistration deadline: March 29, 2019Registration on site is possible.

LIMITED NUMBER OF PARTICIPANTSThe workshops and the evening events have a limitednumber of participants due to room capacity.

Ch

arité M

ayo C

on

feren

ce

23

REGISTRATION FEESTotal Conference FeeEUR 350EUR 250 for members of AGO, NOGGO,PARSGO or ESGO and assistant physiciansDay-TicketsEUR 130 per dayEUR 100 per day for members of AGO, NOGGO,PARSGO or ESGO and assistant physiciansIntensive Workshop Ovarian CancerEUR 50 (additional charge)Intensive Workshop Breast SurgeryEUR 50 (additional charge)Intensive Workshop Cervical CancerEUR 50 (additional charge)Welcome EveningEUR 20 per personFestive EveningEUR 50 per person

REGISTRATION TERMSPlease see registration form in the middle of this booklet.

ACCREDITATIONCME-Points will be submitted at theMedical Association Berlin.

CONFERENCE OFFICEThe conference office is located on the ground floor of theconference venue. The office opens 60 minutes before theprogram starts.

CONFERENCE TELEPHONE+49(0)30/24048385(only during the conference days: April 3–6, 2019)

Ch

arit

é M

ayo

Co

nfe

ren

ce

Travel and Hotel

24

VENUE ADDRESSLangenbeck-Virchow-HausLuisenstraße 58/59, 10117 Berlin / Germanywww.langenbeck-virchow-haus.de

TRAVEL INFORMATION

AIRPLANE Airports Tegel (TXL) and Schönefeld (SXF). Express Bus TXL from TXL to the city; bus stop next to the conference venue: “Invalidenpark”. Local train S9 from SXF to Berlin Main Station (Hauptbahnhof).

TRAIN Berlin Main Station (Hauptbahnhof) is about 1 km from the conference venue: taxi or bus line 147

CAR No parking lot at the conference venue! Public parking space is very limited! Nearest car park: APCOA Parkhaus, Luisenstraße 47 (about 500 m)

PUBLIC TRANSPORT Bus line 147 from Main Station (direction Ostbahnhof via Friedrichstraße) stops right in front of the venue: bus stop “Charité Campus Mitte”.

= Hörsaalruine = Langenbeck-Virchow-Haus

LOCATION WELCOME EVENINGHörsaalruine (Lecture Hall Ruin), MedizinhistorischesMuseum, Virchowweg 16 at the Charité Campus Mitte(a few minutes walk from the conference venue)

BerlinMain Station

Ch

arité M

ayo C

on

feren

ce

25

HOTEL SEARCH AND BOOKINGAt the official Berlin Website, you can find a booking portal.www.berlin.de (EN: Tourism & Travel / DE: Tourismus)

ROOM CONTINGENTSA contingent of rooms has been reserved for conferenceparticipants at the following hotels (booking directly at thehotel, keyword “Charité-Mayo”; valid until March 5, 2019;limited – no guarantee of availability):

HOTEL ALBRECHTSHOF Albrechtstraße 8, 10117 Berlin (about 750 m from the conference venue) +49 (0)30/30886-0 [email protected] www.hotel-albrechtshof.de} single room: EUR 129 (including breakfast)

H+ HOTEL BERLIN MITTE Chausseestraße 118, 10115 Berlin (about 850 m from the conference venue) +49 (0)30/278755-0 [email protected] www.h-hotels.com} single room: EUR 112 (including breakfast)} double room: EUR 122 (including breakfast)

FURTHER SUGGESTIONSAt the conference website, you can find some more hotelsnear the conference venue.www.charite-mayo.de " Hotel

ALL ABOUT BERLIN:www.charite-mayo.de " Berlin Information

Ch

arit

é M

ayo

Co

nfe

ren

ce


26

Abu-Rustum, Prof. Dr. Nadeem R., Gynecology Service, Departmentof Surgery, Memorial Sloan Kettering Cancer Center, New York, NY (USA)

Achimas-Cadariu, Prof. Dr. Patriciu, Gyneco-Oncologic Surgery,Institutul Oncologic „Prof. Dr. Ion Chiricuta”, Cluj-Napoca (RO)

Armbrust, Dr. med. Robert, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Berek, Prof. Dr. Jonathan S., Stanford Cancer Center, Department:Obstetrics and Gynecology – Oncology, Stanford University, Stanford, CA (USA)

Birrer, Prof. Dr. Michael J., Comprehensive Cancer Center, University ofAlabama at Birmingham, Birmingham, AL (USA)

Blohmer, Prof. Dr. med. Jens-Uwe, Department of Gynecology andBreast Center, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

du Bois, Prof. Dr. med. Dr. h.c. Andreas, Department ofGynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)

Bookman, Dr. Michael, Department of Gynecologic Oncology, UCSFMedical Center, San Francisco, CA (USA)

Braicu, Prof. Dr. med. Elena Ioana, Department of Gynecology withCenter for Oncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin (D)

Camara, Priv.-Doz. Dr. med. Oumar, Breast Center, HufelandKlinikum, Bad Langensalza (D)

Chiantera, Prof. Dr. Vito, Gynecologic Oncology, Arnas Civico – Policlinicodi Palermo, Palermo (I)

Cibula, Prof. Dr. David, Department of Obstetrics and Gynaecology, FirstFaculty of Medicine, Charles University and General University Hospital Prague,Praha (CZ)

Chekerov, Dr. med. Radoslav, Department of Gynecology with Centerfor Oncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin (D)

Chiva, Dr. Luis, Department of Obstetrics and Gynecology, Clinica Universidadde Navarra, Madrid (E)

Cliby, Prof. Dr. William A., Department of Obstetrics and Gynecology,Mayo Clinic, Rochester, MN (USA)

Colombo, Prof. Dr. Nicoletta, Department of Medicine and Surgery,Università Milano-Bicocca, European Institute of Oncology, Milano (I)

Concin, Prof. Dr. Nicole, University Hospital for Women’s Health,Innsbruck (A)

Dorigo, Prof. Dr. Oliver, Gynecology Clinic, Department: Obstetrics andGynecology – Oncology, Stanford University, Stanford, CA (USA)

Dowdy, Prof. Dr. Sean C., Department of Obstetrics and Gynecology,Mayo Clinic, Rochester, MN (USA)

Fotopoulou, Prof. Dr. med. Christina, Department of Gynecologywith Center for Oncological Surgery, Charité – Universitätsmedizin Berlin, CampusVirchow-Klinikum, Berlin (D) + Obstetrics and Gynecology, Gynecologic Oncology,Hammersmith Hospital, Queen Charlotte's and Chelsea Hospital, London (UK)

Ch

arité M

ayo C

on

feren

ce

27

Fujiwara, Prof. Dr. Keiichi, Department of Gynecologic Oncology, SaitamaMedical University International Medical Center, Saitama (JP)

Gluz, Priv.-Doz. Dr. med. Oleg, Breast Center Niederrhein,Evangelisches Krankenhaus Bethesda, Mönchengladbach (D)

González Martín, Dr. Antonio, Department of Medical Oncology,Clinica Universidad de Navarra, Madrid (E)

Gourley, Prof. Dr. Charlie, Edinburgh Cancer Research Centre, Institute ofGenetics and Molecular Medicine, The University of Edinburgh, Edinburgh (UK)

Grabowski, Dr. med. Jacek, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Gultekin, Prof. Dr. Murat, Department Obstetrics and Gynecology,Hacettepe University Hospital, Ankara (TR)

Heil, Prof. Dr. med. Jörg, Breast Center, Women’s Health and Obstetrics,Universitätsklinikum Heidelberg, Heidelberg (D)

Herzog, Prof. Dr. Thomas, UC Cancer Institute, University of Cincinnati,Cincinnati, OH (USA)

Hummel, Prof. Dr. rer. nat. Michael, Institute of Pathology, Charité –Universitätsmedizin Berlin, Berlin (D)

Inci, Dr. med. Gülhan, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Ivanov, Prof. Dr. Nikita Vladimirovich, Department ofEndocrinology, North-Western State Medical University V. G. Baranov,St. Petersburg (RUS)

Karsten, Dr. med. Maria, Department of Gynecology and Breast Center,Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

Kaufmann, Priv.-Doz. Dr. rer. nat. Andreas, Department ofGynecology with Center for Oncological Surgery, Charité – Universitätsmedizin Berlin,Campus Virchow-Klinikum, Berlin (D)

Keilholz, Prof. Dr. med. Ulrich, Charité Comprehensive Cancer Center(CCCC), Charité – Universitätsmedizin Berlin, Berlin (D)

Kiver, Verena, Department of Gynecology and Breast Center, Charité –Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

Körber, Dr. med. Mareike, Clinic of Anesthesiology and OperativeIntensive Medicine, Charité – Universitätsmedizin Berlin, Campus Charité Mitte,Berlin (D)

Kolberg-Liedtke, Prof. Dr. med. Cornelia, Department ofGynecology and Breast Center, Charité – Universitätsmedizin Berlin, Campus CharitéMitte, Berlin (D)

Kümmel, Prof. Dr. med. Sherko, Department of Senology /Interdisciplinary Breast Center, Evang. Kliniken Essen-Mitte, Essen (D)

Kulbe, Dr. med. Hagen, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Ledermann, Prof. Dr. Jonathan, UCL Cancer Institute, UniversityCollege London, London (UK)

Ch

arit

é M

ayo

Co

nfe

ren

ce


28

Lee, Prof. Dr. Adrian, Magee-Women’s Research Institute, Department ofPharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA (USA)

Lichtenegger, Prof. Dr. med. Werner, Department of Gynecologywith Center for Oncological Surgery, Charité – Universitätsmedizin Berlin, CampusVirchow-Klinikum, Berlin (D)

Liu, Dr. Minetta, Department of Oncology, Mayo Clinic, Rochester, MN (USA)

Maatouk, Dr. Rabih, Clinic Dr Rabih Maatouk, Mtayleb (LBN)

Mahner, Prof. Dr. med. Sven, Clinic and Polyclinic of Gynecology andObstetrics, Campus Innenstadt and Campus Großhadern, Klinikum der Ludwig-Maximilians-Universität München, München (D)

Marnitz-Schulze, Prof. Dr. med. Simone, Clinic and Polyclinic ofRadiooncology, Cyberknife- and Radiotherapy, Uniklinik Köln, Köln (D)

Marth, Prof. Dr. med. Christian, University Hospital for Women’sHealth, Innsbruck (A)

Mechsner, Prof. Dr. med. Sylvia, Department of Gynecology withCenter for Oncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin (D)

Mirza, Dr. Mansoor Raza, Department of Oncology, Rigshospitalet,Copenhagen University Hospital, København (DK)

Monk, Prof. Dr. Bradley, The University of Arizona Cancer Center,Department of Obstetrics and Gynecology, University of Arizona College of Medicine,Phoenix, AZ (USA)

Muallem, Priv.-Doz. Dr. med. Dr. med. (syr) Mustafa Zelal,Department of Gynecology with Center for Oncological Surgery, Charité –Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin (D)

Neymeyer, Dr. med. Jörg, Clinic of Urology, Charité – UniversitätsmedizinBerlin, Campus Benjamin Franklin, Berlin (D)

Oesterreich, Prof. Dr. Steffi, Department of Pharmacology and ChemicalBiology, University of Pittsburgh, Pittsburgh, PA (USA)

Paepke, Dr. med. Dipl.-Med. Stefan, Interdisciplinary Breast Center,Clinic and Polyclinic for Women’s Health, Klinikum rechts der Isar der TechnischenUniversität München, München (D)

Pietzner, Dr. med. Klaus, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Pignata, Dr. Sandro, Urogynecological Department, Division of MedicalOncology, National Cancer Institute G. Pascale Foundation, Napoli (I)

Podratz, Prof. Dr. Karl C., Department of Obstetrics and Gynecology,Mayo Clinic, Rochester, MN (USA)

Poveda, Prof. Dr. Andrés, Oncogynecologic Department, HospitalQuironsalud, Valencia (E)

Pusztai, Prof. Dr. Lajos, Breast Cancer Translational Research, Yale CancerCenter Genetics, Genomics and Epigenetics Program, Yale School of Medicine,New Haven, CT (USA)

Querleu, Prof. Dr. Denis, Surgery Department, Institut BergoniéComprehensive Cancer Center, Bordeaux (F)

Ch

arité M

ayo C

on

feren

ce

29

Reißhauer, Dr. med. Anett, Center for Musculoskeletal Surgery, Charité –Universitätsmedizin Berlin, Campus Charité Mitte and Campus Benjamin Franklin,Berlin (D)

Scambia, Prof. Dr. Giovanni, Polyclinic Agostino Gemelli, UniversitàCattolica del Sacro Cuore, Roma (I)

Schubert, Dr. med. Melanie, Department of Gynecology and BreastCenter, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

Seckl, Prof. Dr. Michael, Faculty of Medicine, Department of Surgery ofCancer, Imperial College London, London (UK)

Sehouli, Prof. Dr. med. Jalid, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Speiser, Dr. med. Dorothee, Department of Gynecology and BreastCenter, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

Tullius, Prof. Dr. Stefan G., Division of Transplant Surgery, Brigham andWomen’s Hospital, Harvard Medical School, Boston, MA (USA)

Wahner-Hendrickson, Dr. Andrea E., Department of Oncology, MayoClinic, Rochester, MN (USA)

von Waldenfels, Dr. med. Gabriel, Department of Gynecology andBreast Center, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin (D)

Wimberger, Prof. Dr. med. Pauline, Clinic and Polyclinic for Women’sHealth and Obstetrics, Universitätsklinikum Carl Gustav Carus an der TechnischenUniversität Dresden, Dresden (D)

Woopen, Dr. med. Hannah, Department of Gynecology with Center forOncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)

Ch

arité M

ayo C

on

feren

ce

31


PLATINUM SPONSOR

GOLD SPONSORS

*

Ch

arit

é M

ayo

Co

nfe

ren

ce


32

SILVER SPONSORS

BRONZE SPONSORS

**

Ch

arité M

ayo C

on

feren

ce

33

PREMIUM SPONSORS

Polytech

Bristol-Myers Squibb ***

Takeda

Novocure (support by an Educational Grant: EUR 6,000)

Roche Diagnostics

Allergosan

Daiichi Sankyo ****

Fresenius Kabi

Genmab (support by a Medical Education Grant)

Riemser

SPONSORS AND EXHIBITORS

IGCS International Gynecologic Cancer Society

Erbe Elektromedizin

Genomic Health

DIZG Deutsches Institut für Zell- und Gewebeersatz

Innocur

Sonoscape

Olympus

Deutsche Stiftung Eierstockkrebs

ESGO – European Society of Gynaecological Oncology

NOGGO – Nord-Ostdeutsche Gesellschaft fürGynäkologische Onkologie

WE THANK ALL SPONSORS ANDEXHIBITORS FOR THEIR SUPPORT!

support: *) EUR 30,000 / **) EUR 10,000 / ***) EUR 7,500 / ****) EUR 5,000

Ch

arit

é M

ayo

Co

nfe

ren

ce

Social Program

34

FESTIVE EVENING

WELCOME EVENING

Hörsaalruine (Lecture Hall Ruin)of the Medizinhistorisches Museum der CharitéCampus Charité Mitte, Virchowweg 16

Evening reception · Dress: formalRegistration fee per person: EUR 20

More at: www.charite-mayo.de Æ Social Program

limited number of participants · only in combination with a conference ticket

Clärchens BallhausAuguststraße 24, 10117 Berlin(www.ballhaus.de)

Evening reception and dinner · Dress: formalRegistration fee per person: EUR 50

More at: www.charite-mayo.de Æ Social Program

limited number of participants · only in combination with a conference ticket

Friday, April 5, 2019 · 8.00 pm

Thursday, April 4, 2019 · 8.00 pm

www.charite-mayo.de

May 5–8, 2021Berlin

th InternationalCharité MayoConference

11Global Perspectives andFuture Directions inWomen’s Cancer

CONFERENCE CHAIRSProf. Dr. med. Jalid, SehouliProf. Dr. med. Jens-Uwe BlohmerCharité – Universitätsmedizin Berlin

SAVE THE DATE

Documents

Global Perspectives and Future Directions in Women’s Cancer · Charité Mayo Conference in Berlin: “Global Perspectives and Future Directions in Women’s Cancer”. This special